XII International symposium. Artificial intelligence in diagnosis and monitoring

About symposium

Dear colleagues, we invite you to take part in the International Webinar: «Controversies in glaucoma: artificial intelligence (AI) in diagnosis and monitoring», which will be held on November 10, 2023.

The use of AI in medicine is the most intriguing, full of contradictions, but at the same time extremely promising. It opens up the possibilities of personalized treatment. This fully applies to the use of AI in glaucoma.

Download the program (PDF)

Add a reminder to your calendar

Reporter

Cheng Ching Yu

Singapore

Professor of Department of Ophthalmology of Yong Loo Lin School of Medicine, National University of Singapore. Scientific Faculty Member of SingHealth Duke-NUS Global Health Institute. Professor Cheng’s primary research interests are related to the epidemiology and genetics of major eye diseases. His current work involves in a variety of epidemiological, clinical, and image research on glaucoma. He directs the Singapore Epidemiology of Eye Diseases (SEED) Program, a large multi-disciplinary research program focusing on epidemiology, imaging and genetics on eye diseases in Singapore. Professor Cheng is on the editorial board of several international journals, including Scientific Reports, British Journal of Ophthalmology, Clinical and Experimental Ophthalmology, Translational Vision Science and Technology, and Ophthalmic Epidemiology. He has received a number of prestigious awards, including Clinician Scientist Award (CSA) from National Medical Research Council, Singapore in 2012 and 2017, the Asia-Pacific Academy of Ophthalmology (APAO) Achievement Award, APAO Outstanding Service in Prevention of Blindness Award, and American Academy of Ophthalmology (AAO) Achievement Award.

Benjamin Yi Xing Xu

USA

Assistant Professor Of Clinical Ophthalmology, Director of Inpatient Ophthalmology Service of Keck Hospital of USC. Dr. Xu’s primary research interest is preventing vision loss and blindness in patients at risk for angle closure glaucoma (ACG), a common type of glaucoma. His research focuses on studying the pathophysiology of ACG and improving the care of angle closure patients. Dr. Xu also uses advanced anterior segment imaging modalities including anterior segment optical coherence tomography (AS-OCT) and ultrasound biomicroscopy (UBM) to study the physiological and biomechanical properties of intraocular structures and aqueous outflow pathways. Finally, Dr. Xu works on designing biomedical devices to assess the function of anterior segment structures, such as the iris and trabecular meshwork. Dr. Xu has coauthored more than 30 peer-reviewed publications and a book on ocular imaging in glaucoma. He has also received numerous research awards, including those from the National Institutes of Health, American Glaucoma Society and Fight for Sight.

Fei Li

China

Dr. Fei Li presently holds the position of assistant professor at Zhongshan Ophthalmic Center, Sun Yat-sen University, and specializes in glaucoma. His research is primarily concentrated on the mechanisms and treatment of glaucoma. As the co-founder of the iChallenge datasets and the lead researcher of the iGlaucoma project, Dr. Li's work extends beyond AI projects to include supervision of research endeavors focused on glaucoma gene therapy and the exploration of neural circuits in glaucoma development. He has been invited to speak at various ophthalmic conferences, such as APAO, APGC, WGC, and AACGC.

Natalia I. Kurysheva

Russia

Head of the Department of Eye Diseases of the Federal Medical and Biological University of Innovations and Continuing Education of the FMBA of Russia; Professor of the Department of Ophthalmology of the APO of the FSBI FNCC of the FMBA of Russia; Head of the Consultative and Diagnostic Department of the Center of Ophthalmology of the FMBA of Russia; a member of the European Glaucoma Society and the American Academy of Ophthalmology; honorary member of the Italian Glaucoma Society; scientific supervisor and coordinator of the Federal Target Group Programs “Glaucoma Opticoneuropathy”. Natalia is a representative of Russian Ophthalmology in the European Association of Predictive, Preventive and Personalized Medicine. The research interests: etiology, pathogenesis, laser and surgical treatment of glaucoma, neuroprotection, angle-closure, normotensive and pseudoexfoliative glaucoma, retinal diseases. For the last 10 years, she has been studying new methods of optic nerve and retina visualization in glaucoma, the progression of the disease, and ocular blood flow and the personalized treatment of the primary angle clouser. Author of more than 300 scientific papers, including 50 papers in international peer-reviewed journals, 10 monographs on the diagnosis and treatment of glaucoma and ocular blood flow, as well as 10 patents for inventions. Member of the editorial board of the National Journal of Glaucoma (Russia) and Ophthalmology Journal (Russia), a reviewer of the British Journal of Ophthalmology (BJO), Bulletin of Ophthalmology and other prominent international journals. She was awarded by the Ministry of Education of the Russian Federation for scientific research on topical issues of fundamental and applied science in the field of education, achievements in the training of highly qualified specialists, for the introduction of new forms and methods of teaching in the educational process. The author of two recent monographs: COVID-19 and visual organ damage, 2021, and Dry age-related macular degenerations, 2021, a member of International Optical Circulation Society (IOCS).

Xiulan Zhang

China

Prof. Xiulan Zhang, MD, PhD, glaucoma specialist, is currently at Zhongshan Ophthalmic Center, Sun Yat-sen University, China. She was among the Top 50 Experts in Worldwide Glaucoma Expertscape 2019-2024 and She was listed as the Top 100 most influential people in ophthalmology Power List in 2023 and 2014. She is the Fellow of the Academy of Asia-Pacific Professor of Ophthalmology (AAPPO). She is the board member of the Asia-Pacific Glaucoma Society (APGS), the Asia-Pacific Ocular Imaging Society (APOIS) and International AI in Ophthalmology Society (IAIOph). She serves as the Convener of the Glaucoma Scientific Program of Asia-Pacific Academy of Ophthalmology (APAO 2024 , 2019 and2018). She was awarded the Distinguished Service Award of APAO in 2021, the Achievement Award of APAO in 2017 and the Prestigious Achievement Award of Ophthalmic Image Analysis in 2019. <br>Prof. Zhang has published 182 SCI articles, with H-index of 44 (Google Scholar). Fourteen high impact articles (IF>10) including Ophthalmology, Journal of Clinical Investigation, NPJ Digital Medicine and Medical Image Analysis. She oversees an extraordinarily productive glaucoma clinical research team that has impacted diagnostics, and our management of myopia and glaucoma surgery. She organized and oversees an international team of glaucoma experts to develop a novel classification system of visual field defects in highly myopic eyes (Ophthalmology 2022 Jul), and bult up a high myopia normative database of pRNFL to detect myopic glaucoma (Ophthalmology 2023 Jul). She created iGlaucoma, an integrated intelligent glaucoma screening platform based on AI and multimodal imaging (NPJ Digital Medicine 2020, Ophthalmology 2022 Jan, Ophthalmology 2022 Feb, Ophthalmology 2022 Aug and Journal of Clinical Investigation 2022 Jun). Prof Zhang also founded a massive annotated public database “iChallenge” (https://ichallenges.grand-challenge.org/). The database covers major blinding diseases including glaucoma, AMD, PM, and DR (Medical Image Analysis 2020 Jan, 2020 Dec, 2021 Apr and 2023 Sept). <br>Prof. Zhang has published four self-authored books by People’s Medical Publishing House which have been spread worldwide with 36,000 copies, Illustrated Surgical Techniques and Pearls of MIGS (2022); Illustrated anterior segment examinations and diagnosis of glaucoma (2020);Illustrated surgical techniques and pearls of glaucoma (2016); Illustrated clinical diagnosis and treatment of glaucoma (2014) and the Chinese translation of 10 books of the WGA Consensus Series. She has given invited lectures for 698 times domestic and overseas. <br>Prof. Zhang has excellent leadership and founded the first clinical research center for Ophthalmology in China that meets international standard. With her guidance, more than 182 clinical trials have been registered and started in ZOC, whose clinical research center now ranking the first-class in China.

Alexey Antonov

Russia

Leading Researcher, Ph.D. FGBNU "NIIGB named after M.M. Krasnov". Member of the Expert Council on Glaucoma of the All-Russian Public Organization "Association of Ophthalmologists"; Member of the European Glaucoma Society (European Glaucoma Society); Deputy editor-in- chief of the scientific and clinical publication "National Journal of Glaucoma". His research focuses the biomechanical properties of the cornea and sclera, methods for studying intraocular pressure, diagnosis and treatment of glaucoma. Author of 95 scientific papers, including (as an author and co-author): "Ophthalmotonometry" (2009); "Static perimetry in the diagnosis and monitoring of glaucoma" (2016); 15 patents for the invention. GCP certificate, participation in 6 clinical trials (Phase III) as a co-investigator.

Maria Budzinskaya

Moscow, Russian Federation

Doctor of Medical Sciences, prof. of Ophthalmology of the Research Institute of Eye Diseases. She is a member of the Presidium of the Board of the All-Russian Public Organization "Society of Ophthalmologists of Russia". Expert of the Russian Academy of Sciences Member of the editorial board of the journal "Bulletin of Ophthalmology". Since 2011 - Member of the European Society of Retinal Specialists (euretina membership certificate), Member of the Academic and Dissertation Councils of the Research Institute of Eye Diseases. Member of dissertation councils of the Fyodorov Eye Microsurgery Federal State Institution. The main areas of research are ophthalmology, retinology, age-related macular degeneration, diabetic retinopathy, anti-VEGF therapy, clinical trials. Author more than 200 scientific papers have been published. GCP certificate, participation in clinical trials (Phase III) as a co-investigator and principal investigator.

Leopold Schmetterer

Austria-Singapore

Scientific Director and Head of the Eye Visualization Department of the Singapore Eye Research Institute. Professor, Department of Biomedical Engineering, Nanyang Technological University; Honorary Professor of Ophthalmology, Li Kong Chian Medical School, Nanyang Technological University; Visiting Professor, Institute of Ophthalmology, Basel, Switzerland. Professor Schmetterer is involved in many studies of the retina, cornea, glaucoma, and dry eye. He has more than 300 peer-reviewed publications; has been invited to more than 200 lectures; and has received a research funding grant worth more than 35 million Singapore dollars. He is a member of the editorial boards of 10 journals, including Progress in Retinal and Eye Research, Scientific Reports, Acta Ophthalmologica, Journal of Ocular Pharmacology and Therapeutics, Current Eye Research and others, as well as a special reviewer in more than 40 journals.

Program

12.00 – 12.05

Welcoming speech and introductions (Greeting: akad. V.A.Chereshnev, professor B. E. Malyugin, professor V.N. Trubilin)

12.05 – 12.20

AI for all eyes: is glaucoma screening now feasible?

prof. Cheng Ching Yu, Singapore

12.05 – 12.20

12.20 – 12.40

Using AI in Glaucoma Imaging

prof. Benjamin Yi Xing Xu, USA

12.20 – 12.40

12.40 – 13.00

Glaucoma AI: Challenges and Opportunities.

prof. Fei Li, China

12.40 – 13.00

13.00– 13.20

The deep learning in the development of the personalized treatment of PAC.

prof. Kurysheva N., Russia

13.00– 13.20

13.20 – 13.40

Advances of Artificial Intelligence in Glaucoma Management.

prof. Zhang X., China

13.20 – 13.40

13.40– 14.00

What is a role of tonometry in the area of AI?

ph.D. Antonov A., Russia

13.40– 14.00

14.00– 14.20

AI for the detecting of rapidly advancing age-related macular degeneration.

prof Budzinskaya M., Moscow, Russian Federation

14.00– 14.20

14.20– 14.40

Big Thinking with Big Data.

prof. Shmetterer L., Austria-Singapore